Seaspine Holdings Corporation Receivables Turnover Ratio (SPNE), from the third quarter 2022 to the third quarter 2021 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Seaspine Holdings Corporation  (NASDAQ: SPNE)
 

Seaspine Holdings Accounts Receivables Turnover Ratio from the third quarter 2022 to the third quarter 2021

Quarterly Results, Trends, Rankings, Statistics


Seaspine Holdings Corporation's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2022 to a ratio of 6.31, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the third quarter 2022. Average receivable collection period, for the Seaspine Holdings in Sep 30 2022 quarter, has decreased to 58 days, compared to 59 days, in the Jun 30 2022 quarter.

If we take a look into Healthcare sector 214 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2022 from 1812 to 1936.

What is Receivable Turnover Ratio?
What is Seaspine Holdings Corporation Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SPNE Receivables Turnover Ratio (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Receivable Change 34.03 % 16.05 % 44.12 % 38.53 % 24.51 %
Y / Y Revenue Change 44.57 % 18.66 % 20.83 % 19.71 % 7.49 %
Receivable Turnover Ratio (TTM) 6.31 6.16 6.11 6.38 6.63
SPNE's Total Ranking # 1936 # 1812 # 1466 # 1812 # 2271
Accounts Receivable average collection period days 58 59 60 57 55
Seq. Receivable Change 13.15 % -4.52 % -0.44 % 24.61 % -2.03 %
Seq. Revenue Change 19.23 % 11.1 % -8.81 % 19.69 % -2.14 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 90
Healthcare Sector # 215
Overall Market # 1936

Receivable Turnover Ratio Statistics
High Average Low
1.04 0.82 0.52
(Sep 30 2018)   (Mar 31 2022)





SPNE Company Profile • Back to SPNE Efficiency Comparisons • Compare SPNE Receivables Turnover Ratio to its Competitors

Financial Statements
Seaspine Holdings's Accounts Receivable $ 39 Millions Visit SPNE's Balance sheet
Seaspine Holdings's Sales TTM $ 230 Millions Visit SPNE's Income Statement
Sources of SPNE's Revenues Visit SPNE's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SPNE's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SPNE's Growth Rates SPNE's Roa SPNE's Inventory Turnover Ratio SPNE's Dividend Comparisons
SPNE's Profitability Ratios SPNE's Roi SPNE's Asset Turnover Ratio SPNE's Dividend Growth
SPNE's Valuation Ratios SPNE's Roe SPNE's Financial Strength Ratios SPNE's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2022 Receivable at quarter ending Sep 30 2022
Xbiotech Inc   16.18 $ 8.210  Millions$ 0.508  Millions
Palvella Therapeutics Inc   16.17 $ 28.499  Millions$ 1.763  Millions
Poseida Therapeutics Inc   15.68 $ 151.679  Millions$ 9.675  Millions
Qhslab Inc   15.51 $ 1.305  Millions$ 0.084  Millions
Inhibrx Biosciences Inc   15.45 $ 4.774  Millions$ 0.309  Millions
Endonovo Therapeutics Inc   15.04 $ 0.014  Millions$ 0.001  Millions
Cv Sciences Inc   14.99 $ 17.305  Millions$ 1.154  Millions
Fulcrum Therapeutics Inc   14.93 $ 10.715  Millions$ 0.718  Millions
Regenxbio Inc   14.83 $ 480.034  Millions$ 32.378  Millions
Harrow Inc   14.77 $ 88.454  Millions$ 5.991  Millions
Patterson Companies Inc   14.68 $ 6,384.837  Millions$ 434.817  Millions
Neurometrix Inc   14.67 $ 8.229  Millions$ 0.561  Millions
23andme Holding Co  14.39 $ 297.622  Millions$ 20.686  Millions
Rayont Inc   14.32 $ 3.521  Millions$ 0.246  Millions
Travere Therapeutics Inc   14.24 $ 213.399  Millions$ 14.987  Millions
Corcept Therapeutics Inc  14.15 $ 397.624  Millions$ 28.095  Millions
Apellis Pharmaceuticals Inc   14.11 $ 113.049  Millions$ 8.011  Millions
Delcath Systems Inc   14.00 $ 4.190  Millions$ 0.299  Millions
Biofrontera Inc   13.73 $ 42.965  Millions$ 3.130  Millions
Escalon Medical Corp   13.64 $ 10.633  Millions$ 0.779  Millions
Cano Health Inc   13.56 $ 2,468.011  Millions$ 182.046  Millions
Kiniksa Pharmaceuticals International Plc  13.52 $ 177.041  Millions$ 13.098  Millions
Sonendo Inc   13.31 $ 39.317  Millions$ 2.954  Millions
Emmaus Life Sciences Inc   13.16 $ 15.480  Millions$ 1.176  Millions
Nurix Therapeutics Inc   13.08 $ 39.240  Millions$ 3.000  Millions
Myovant Sciences Ltd   12.62 $ 333.323  Millions$ 26.404  Millions
Teladoc Health Inc   12.11 $ 2,323.366  Millions$ 191.905  Millions
Tango Therapeutics Inc   12.08 $ 24.165  Millions$ 2.000  Millions
Astrotech Corp  12.05 $ 0.720  Millions$ 0.060  Millions
Chinook Therapeutics Inc   11.94 $ 56.852  Millions$ 4.761  Millions

Date modified: 2026-10-07T00:41:49+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.